Maravai Lifesciences Holdings Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$41,630	$47,397	$46,850	$56,406
Gross Profit	5,655	7,768	7,725	18,962
EBITDA	-22,463	-51,924	-31,003	-20,713
EBIT	-38,305	-67,310	-45,913	-35,239
Net Income	-25,556	-39,591	-29,945	-26,145
Net Change In Cash	41,630	47,397	46,850	56,406
Free Cash Flow	-18,076	-13,139	-14,625	-20,487
Cash	243,574	269,907	285,053	322,399
Basic Shares	144,683	144,236	143,425	139,730

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$259,185	$288,945	$883,001	$799,240
Gross Profit	108,309	140,202	714,044	658,679
EBITDA	-156,917	712,409	609,989	585,777
EBIT	-213,782	663,628	571,886	561,025
Net Income	-144,846	-119,029	220,205	182,037
Net Change In Cash	259,185	288,945	883,001	799,240
Cost of Revenue				315,176
Free Cash Flow	-22,193	60,671	518,887	353,720
Cash	322,399	574,962	632,138	551,272
Basic Shares	137,906	131,919	131,695	121,965